Baidu
map

Clin Infect Dis:抗菌药物耐药影响社区中常见感染患者的恢复?

2017-08-15 梁舒瑶 环球医学资讯

2017年5月,发表在《Clin Infect Dis》的一项由英国科学家进行的系统回顾和Meta分析,考察了抗菌药物耐药对社区中常见感染患者恢复的影响。

2017年,发表在《Clin Infect Dis》的一项由英国科学家进行的系统回顾和Meta分析,考察了抗菌药物耐药对社区中常见感染患者恢复的影响。

背景:抗菌药物的使用是抗菌药物耐药菌的主要驱动原因。有一种观念认为,在社区中,因抗菌药物耐药而导致的抗菌治疗失败具有很小的临床影响。

方法:研究人员检索了截止到2016年4月15日的Medline、Embase、Pubmed、Cochrane临床对照试验资料库和科学网,无语言限制。纳入的研究都以社区为基础,并报道了实验室证实的感染(呼吸道、尿道、皮肤或软组织)、抗菌药物耐药和临床结局等患者水平的数据。首要结局为临床应答失败。次要结局为复诊、进一步抗菌药物处方、症状持续时间、症状严重程度。可能的情况下,研究人员使用随机效应模型的Meta分析计算了比值比及其95%可信区间。

结果:研究人员纳入了26项研究(5659人)。抗菌药物耐药的大肠杆菌尿路感染(OR,4.19;95% CI,3.27~5.37;2432人)、肺炎链球菌中耳炎(OR,2.51;1.29~4.88;921人)、肺炎支原体社区获得性肺炎(OR,2.15;1.32~3.51;916人)的参与者临床应答失败的可能性更显着。临床异质性排除了Meta分析中金黄色葡萄球菌皮肤或软组织感染的首要结局。

结论:抗菌药物耐药显着影响社区患者的疾病负担。实验室证实的抗菌药物耐药的尿路和呼吸道感染患者在抗菌药物治疗后更可能临床恢复延迟。更好地掌握抗菌药物耐药风险对患者重要结局的影响,将促成医务人员和患者就常见感染的抗菌药物治疗进行更有意义的讨论。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2012364, encodeId=7bd22012364ab, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Apr 26 11:26:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330592, encodeId=4278133059285, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Thu Aug 17 06:26:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373026, encodeId=3e6f13e302636, content=<a href='/topic/show?id=eb2555e176c' target=_blank style='color:#2F92EE;'>#抗菌药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55717, encryptionId=eb2555e176c, topicName=抗菌药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Thu Aug 17 06:26:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395701, encodeId=9f9d1395e019e, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Thu Aug 17 06:26:00 CST 2017, time=2017-08-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2012364, encodeId=7bd22012364ab, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Apr 26 11:26:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330592, encodeId=4278133059285, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Thu Aug 17 06:26:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373026, encodeId=3e6f13e302636, content=<a href='/topic/show?id=eb2555e176c' target=_blank style='color:#2F92EE;'>#抗菌药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55717, encryptionId=eb2555e176c, topicName=抗菌药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Thu Aug 17 06:26:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395701, encodeId=9f9d1395e019e, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Thu Aug 17 06:26:00 CST 2017, time=2017-08-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2012364, encodeId=7bd22012364ab, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Apr 26 11:26:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330592, encodeId=4278133059285, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Thu Aug 17 06:26:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373026, encodeId=3e6f13e302636, content=<a href='/topic/show?id=eb2555e176c' target=_blank style='color:#2F92EE;'>#抗菌药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55717, encryptionId=eb2555e176c, topicName=抗菌药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Thu Aug 17 06:26:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395701, encodeId=9f9d1395e019e, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Thu Aug 17 06:26:00 CST 2017, time=2017-08-17, status=1, ipAttribution=)]
    2017-08-17 lhlxtx
  4. [GetPortalCommentsPageByObjectIdResponse(id=2012364, encodeId=7bd22012364ab, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Apr 26 11:26:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330592, encodeId=4278133059285, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Thu Aug 17 06:26:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373026, encodeId=3e6f13e302636, content=<a href='/topic/show?id=eb2555e176c' target=_blank style='color:#2F92EE;'>#抗菌药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55717, encryptionId=eb2555e176c, topicName=抗菌药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Thu Aug 17 06:26:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1395701, encodeId=9f9d1395e019e, content=<a href='/topic/show?id=7a89e4036eb' target=_blank style='color:#2F92EE;'>#社区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74036, encryptionId=7a89e4036eb, topicName=社区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96f62500201, createdName=12498e67m28暂无昵称, createdTime=Thu Aug 17 06:26:00 CST 2017, time=2017-08-17, status=1, ipAttribution=)]

相关资讯

Fertil Steril:胚泡移植前糖皮质激素和抗菌药物使用对妊娠率有何影响?

2017年6月,发表在《Fertil Steril》的一项由美国科学家进行的回顾性队列研究,考察了胚泡移植(ET)前糖皮质激素和抗菌药物使用的结局。

BMJ:非复杂性下呼吸道感染为何**延迟抗菌药物使用?

急性非复杂性呼吸道感染是发达国家初级医疗中最常见的急性疾病,相当多的患者依然接受抗菌药物治疗。发表在《BMJ》的一项由英国和美国科学家进行的前瞻性咳嗽并发症队列(3C)研究,考察了非复杂性下呼吸道感染的抗菌药物处方策略和不良结局。

Lancet Infect Dis:术前抗菌药物预防 手术前早期还是晚期给药?

术前早期还是晚期使用抗菌药物预防?2017年6月,发表在《Lancet Infect Dis》的一项3期随机对照研究调查了术前抗菌药物预防最佳给药时机。

CMAJ:医生的历史处方行为对抗菌药物开始、选择和治疗时间的影响

在长期保健机构中,抗菌药物是最常见的处方药之一。但许多处方都存在不合适或药物使用疗程过长等问题。这意味着这些机构附近的居民有可能暴露于可避免的伤害,包括过敏、器官特异毒和产生耐药性等。2017年6月,发表在《CMAJ》的一项由加拿大科学家进行的研究,考察了长期照机构中,医生的历史处方行为是否能预测当前的处方行为。

警惕!这类药门诊被禁用!六大科室纳入重点监控!

当下中国,抗菌药物使用正面临着前所未有的挑战。山东省卫计委近日发布了《关于加强抗菌药物临床应用管理遏制细菌耐药工作的通知》,对各级医疗机构的采购、管理和使用做出了详细的规定。

Br J Clin Pharmacol:妊娠期使用哪些抗菌药物与重大先天畸形风险相关?

2017年7月,发表在《Br J Clin Pharmacol》的一项由加拿大科学家进行的基于人群的队列研究,考察了妊娠期使用抗菌药物与重大先天畸形风险之间的相关性。

Baidu
map
Baidu
map
Baidu
map